Earnings NewsAmarillo Biosciences GAAP EPS of -$0.51, revenue of $1.75MNov. 07, 2022 8:46 AM ETAinos, Inc. (AIMD) StockBy: Urvi Shah, SA News Editor Amarillo Biosciences press release (NASDAQ:AIMD): Q3 GAAP EPS of -$0.51. Revenue of $1.75M (+386.1% Y/Y). Recommended For YouMore Trending NewsSee More »About AIMD StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgAIMD--Ainos, Inc.Trending AnalysisTrending News